Tetracycline Hydrochloride Capsules

Resteclin (Tetracycline Hydrochloride Capsules) - Product Information

Resteclin (Tetracycline Hydrochloride Capsules) is an antibiotic that works by stopping the growth of bacteria and is used to treat a wide variety of bacterial infections, including Respiratory tract infections, Urinary tract infections, Skin Infections, Ophthalmic infections, Rickettsial infections and acne. Tetracycline Hydrochloride Capsules can also be used in combination with anti-ulcer medications to treat certain types of stomach ulcers.
Tetracycline antibiotic treats only bacterial infections. This medicine will not work for viral infections (e.g., common cold, flu). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Resteclin capsules are manufactured by Abbott India Limited in the strengths of 250 mg and 500 mg.

We also have in stock Augmentin (Amoxicillin and Clavulanate Potassium Tablets) which is an antibiotic which is used for the short term treatment of bacterial infections in different parts of the body.

Name of the Drug

We supply original Resteclin Capsules manufactured by Abbott India Limited.

Manufacturer of Resteclin Capsules

Abbott India Limited  
Website: www.abbott.co.in

Active Ingredient present in Resteclin Capsules

The active ingredient present in Resteclin capsules is Tetracycline Hydrochloride. Each Resteclin capsule contains 250 mg or 500 mg of Tetracycline.

Uses of Resteclin (Tetracycline Hydrochloride Capsules)

Resteclin (Tetracycline Hydrochloride Capsules) are used to treat the following indications:

• Respiratory tract infections: Pneumonia and other lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae and other organisms. Mycoplasma pneumoniae pneumonia. Also treatment of chronic bronchitis (including the prophylaxis of acute exacerbations) and whooping cough.
• Urinary tract infections: Caused by susceptible strains of the Klebsiella species. Enterobacter species, Escherichia coli, Streptococcus faecalis and other organisms.
• Sexually transmitted diseases: Infections due to Chlamydia trachomatis including uncomplicated urethral, endocervical or rectal infections. Non-gonococcal urethritis caused by Ureaplasma urealyticum. Tetracycline is also indicated in chancroid, granuloma inguinale and lymphogranuloma venereum. Tetracycline is an alternative drug in the treatment of penicillin resistant gonorrhoea and syphilis.
• Skin Infections: Acne vulgaris when antibiotic therapy is considered necessary and severe rosacea.
• Ophthalmic infections: Trachoma, although the infectious agent, as judged by immunofluorescence, is not always eliminated. Inclusion conjunctivitis may be treated with oral tetracycline alone or in combination with topical agents.
• Rickettsial infections: Rocky Mountain spotted fever, typhus group, Q fever and Coxiella endocarditis and tick fevers.
• Other infections: Stagnant loop syndrome. Psittacosis, brucellosis (in combination with streptomycin), cholera, bubonic plague, louse and tick-borne relapsing fever, tularaemia, glanders, melioidosis and acute intestinal amoebiasis (as an adjunct to amoebicides).

Tetracycline is an alternative drug in the treatment of leptospirosis, gas-gangrene and tetanus.

Tetracycline Hydrochloride Capsules (Resteclin) - Dosage

Resteclin (Tetracycline Hydrochloride Capsules) should be given one hour before or two hours after meals, since food and some dairy products interfere with absorption. Treatment should be continued for up to three days after symptoms have subsided. Take each dose with a full glass of water (240 mL) unless your doctor tells you otherwise. Do not lie down for 10 minutes after taking this medication. For this reason, do not take this medicine right before bedtime.

All infections due to Group A beta-haemolytic streptococci should be treated for at least 10 days.
Adults (including the elderly) and children over 12 years:
The minimum recommended dosage is 250 mg every six hours. Beneficial levels of this medicine are attained more rapidly by the administration of 500mg initially, followed by 250 mg every six hours. For severe infections, the dosage may be increased to 500mg every six hours.

Dosage recommendations in specific infections:
Skin infections:
250 mg to 500mg daily in single or divided doses should be administered for at least three months in the treatment of acne vulgaris and severe rosacea.

Streptococcal infections:
A therapeutic dose of tetracycline should be administered for at least 10 days.

Brucellosis:
500mg tetracycline four times daily accompanied by streptomycin.

Sexually transmitted diseases:
500mg four times daily for seven days is recommended in the following infections: Uncomplicated gonococcal infections (except anorectal infections in man); uncomplicated urethral, endocervical or rectal infection caused by Chlamydia trachomatis; non-gonococcal urethritis caused by Ureaplasma urealyticum. Acute epididymo-orchitis caused by Chlamydia trachomatis, or Neisseria gonorrhoea, 500mg four times daily for 10 days. Primary and secondary syphilis:
500mg four times daily for 15 days. Syphilis of more than one year's duration, (latent syphilis of uncertain or more than one year's duration, cardiovascular or late benign syphilis) except neurosyphilis, should be treated with 500mg, four times daily for 30 days.

Tetracycline Hydrochloride Capsules (Resteclin) Storage

Store Tetracycline Hydrochloride Capsules (Resteclin) at controlled room temperature (68°F to 77°F, 20°C to 25°C). Keep this medicine out of the sight and reach of children. Protect from light.

Resteclin Capsules Contraindications

Resteclin Capsules are contraindicated in patients with a hypersensitivity to Tetracycline Hydrochloride or any inactive ingredient present in tablets. Resteclin (Tetracycline Hydrochloride Capsules) is also contraindicated in the following cases:

• Chronic renal/hepatic dysfunction.
• Renal impairment, particularly if severe.
• Systemic lupus erythematosus.
• Children under 12 years.
• Pregnancy and breastfeeding women.
• Benign intracranial hypertension has been reported following the concomitant use of Tetracyclines and Vitamin A or retinoids and therefore concurrent use should be contraindicated

Tetracycline Hydrochloride Capsules Warnings and Precautions

The use of drugs of the tetracycline-class like Tetracycline Hydrochloride Capsules (Resteclin) during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown).This adverse reaction is more common during long-term use of the medicines but it has been observed following repeated short-term courses.
All tetracyclines form a stable calcium complex in any bone forming tissue. A decrease in fibula growth rate has been observed in premature infants given oral tetracycline in doses of 25 mg/kg every six hours. This reaction was shown to be reversible when the drug was discontinued.
Results of animal studies indicate that Tetracyclines cross the placenta, are found in fetal tissues and can have toxic effects on the developing fetus (often related to retardation of skeletal development). Evidence of embryotoxicity has also been observed in animals treated early in pregnancy. If this medicine is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. Tetracycline Hydrochloride Capsules should not be used during pregnancy unless absolutely necessary.
If renal impairment exists, even usual oral or parenteral doses may lead to excessive systemic accumulation of the drug and possible liver toxicity. Under such conditions, lower than usual total doses are indicated, and, if therapy is prolonged, serum level determinations of the drug may be advisable.
Photosensitivity manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. Patients apt to be exposed to direct sunlight or ultraviolet light should be advised that this reaction can occur with tetracycline drugs. Treatment should be discontinued at the first evidence of skin erythema.
The antianabolic action of the tetracyclines may cause an increase in BUN. While this is not a problem in those with normal renal function, in patients with significantly impaired renal function, higher serum levels of tetracycline may lead to azotemia, hyperphosphatemia and acidosis.
As with other antibiotics, use of this medicine could result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, the antibiotic should be discontinued and appropriate therapy should be instituted.

Tetracycline Hydrochloride Capsules With Food And Drink

Do not take Tetracycline Hydrochloride Capsules (Resteclin) at the same time as milk or food, as they can make the medicine less effective.

Tetracycline Hydrochloride Capsules (Resteclin) Side Effects

The possible Tetracycline Hydrochloride Capsules (Resteclin) side effects are given below:

• Gastrointestinal: anorexia, nausea, epigastric distress, vomiting, diarrhea, glossitis, black hairy tongue, dysphagia, enterocolitis, and inflammatory lesions (with monilial overgrowth) in the anogenital region.
• Rare instances of esophagitis and esophageal ulceration have been reported in patients receiving particularly the capsule and also the tablet forms of tetracyclines. Most of the patients were reported to have taken medication immediately before going to bed.
• Teeth: permanent discoloration of teeth may be caused during tooth development. Enamel hypoplasia has also been reported
• Skin: maculopapular and erythematous rashes. Exfoliative dermatitis has been reported but is uncommon. Onycholysis and discoloration of the nails have been reported rarely.
• Renal toxicity: rise in BUN has been reported and is apparently dose related.
• Liver: hepatotoxicity and liver failure have been observed in patients receiving large doses of tetracycline and in tetracycline-treated patients with renal impairment.
• Hypersensitivity reactions: urticaria, angioneurotic edema, anaphylaxis, anaphylactoid purpura, pericarditis, exacerbation of systemic lupus erythematosus, and serum sickness-like reactions, as fever, rash, and arthralgia.
• Blood: hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, neutropenia and eosinophilia have been reported.
• Other: bulging fontanels in infants and intracranial pressure in adults
• When given over prolonged periods, tetracyclines have been reported to produce brown-black microscopic discoloration of thyroid glands. No abnormalities of thyroid function studies are known to occur.

Stop taking Resteclin Capsules immediately and seek urgent medical advice in case the following symptoms occur:

• Symptoms of an allergic reaction: skin rash which may be itchy, swelling of your face, eyelids, lips or tongue, sudden wheezing, chest pain or tightness, breathing difficulties, collapse.
• Symptoms of raised pressure in the skull: headache, dizziness, 'ringing' in the ears, visual problems including blurred vision, 'blind spots', double vision.
• Symptoms of a severe skin rash: this may include fever, blisters or ulcers, reddening, peeling or swelling of the skin.
• A decrease in or loss of vision/eyesight
• Severe or prolonged diarrhoea which may have blood or mucus in it, during or after treatment with Tetracycline, as this may be a sign of serious bowel inflammation.
• Inflammation of the pancreas causing pain and tenderness in the abdomen and back (pancreatitis)

Tetracycline Hydrochloride Capsules (Resteclin) Overdosage

Tetracycline Hydrochloride Capsules Overdose symptoms could include nausea and vomiting and hypersensitivity reactions. Crystalluria and haematuria may occur following very large overdose.

There is no specific antidote. In case of overdosage, discontinue medication and institute supportive measures. General symptomatic therapy as indicated by the patient's clinical condition is recommended. Tetracycline is not dialyzable. Gastric decontamination is not necessary. Give oral fluids for severe vomiting and diarrhoea if required. Manage anaphylaxis reactions conventionally.Single brief convulsions do not require treatment. If frequent or prolonged control with intravenous diazepam or lorazepam.

Tetracycline Hydrochloride Capsules During Pregnancy

Tetracycline Hydrochloride Capsules (Resteclin) has been classified by the US FDA as Pregnancy Category D. This medicine should not be used in pregnancy unless essential to the patient's welfare. Tetracyclines cross the placenta and may have toxic effects on foetal tissues, particularly on skeletal development. If Resteclin Capsules is used during pregnancy, or if the patient becomes pregnant while taking this medicine, the patient should be told of the potential hazard to the foetus.

Do not use this medicine without your doctor's consent in case you are pregnant. Stop using this medication and inform your doctor immediately if you become pregnant during treatment.

Tetracycline Hydrochloride Capsules - Nursing Considerations

Tetracyclines are also excreted in breast milk and are therefore Resteclin Capsules (Tetracycline Hydrochloride Capsules) are contraindicated in nursing mothers.

Because of the potential for serious adverse reaction in nursing infants from tetracyclines, a decision should be made whether to discontinue the medicine, taking into account the importance of the drug to the mother
Do not use this medication without telling your doctor if you are breast-feeding a baby.

Buy Tetracycline Hydrochloride Capsules (Resteclin) Online at Only $0.14 per Pill

You can buy Tetracycline Hydrochloride Capsules online from Clear Sky Pharmacy at a cheap price. Resteclin 250 mg and 500 mg capsules, manufactured by Abbott India Limited are supplied in a blister strip of 10 tablets. The 250 mg capsules cost only $0.14 per unit when you place an order for 500 capsules.

Disclaimer

The above information is provided to the best of our knowledge and in good faith, it is without a warrant of any kind, expressed or implied.

Shipping Restriction